c
2
12
18
28
12
12
1a
14
e
12
16
a
a
2
2
a
20
32
1a
2a
19
Faculty
61 16
19
1
49
2
2
1a
32
34
1b
1d
18
79
34
1d
2 29
1d
25
34
Joel M Gelfand, MD MSCE
66James J. Leyden, M.D. Endowed Professor in Clinical Investigation
7
62
Department: Dermatology
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
53
4
3
3
3
2
4
b
1f
53
Perelman Center for Advanced Medicine
1e 7th Floor, South Tower
2c Suite 730
Philadelphia, PA 19104
26
1e 7th Floor, South Tower
2c Suite 730
Philadelphia, PA 19104
35
f
13
Education:
21 a B.S. 26 (Biology, Community Health) c
29 Tufts University, 1993.
21 9 M.D. c
2f Harvard Medical School, 1998.
21 d M.S.C.E. 19 (Epidemiology) c
33 University of Pennsylvania, 2003.
c
3
27
21 a B.S. 26 (Biology, Community Health) c
29 Tufts University, 1993.
21 9 M.D. c
2f Harvard Medical School, 1998.
21 d M.S.C.E. 19 (Epidemiology) c
33 University of Pennsylvania, 2003.
c
Links
72 Faculty Website
7d Dermatology Clinical Effectiveness Research Network (DCERN)
6d Dr. Gelfand Clinical Research Lab
c
5
3
3
8f
Permanent link72 Faculty Website
7d Dermatology Clinical Effectiveness Research Network (DCERN)
6d Dr. Gelfand Clinical Research Lab
c
2 29
21
1e
1d
24
73
e 29
27
Description of Other Expertise
1b Dermatologye 29
23
121 Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T: Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53(4): 573, Oct 2005.
e9 Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB: The risk of lymphoma in patients with psoriasis. J Invest Dermatol 126(10): 2194-201, Oct 2006.
ed Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB: The risk of stroke in patients with psoriasis. J Invest Determatol 129(10): 2411-8, Oct 2009.
13a Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM: Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31(8): 1000-6, Apr 2010.
172 Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, Gelfand JM: The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol 64(6): 1035-50, Jun 2011.
1bf Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM: Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 147(9): 1031-9, Sep 2011.
13f Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM: Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 132(3Pt1): 556-62, Mar 2012.
1d6 Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees AS: Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol 148(4): 487-94, Apr 2012.
12e Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM: Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol 148(9): 995-1000, Sep 2012.
149 Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A: Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). J Vis Exp 63: e3777, May 2012.
181 Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, Gelfand JM: Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol 68(1): 64-72, Jan 2013.
2c
7
1d
1f
Selected Publications
10f Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, and Troxel AB: Risk of Myocardial Infarction in Patients with Psoriasis. Journal of the American Medical Association 296(14): 1735-41, Oct 2006.121 Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T: Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53(4): 573, Oct 2005.
e9 Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB: The risk of lymphoma in patients with psoriasis. J Invest Dermatol 126(10): 2194-201, Oct 2006.
ed Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB: The risk of stroke in patients with psoriasis. J Invest Determatol 129(10): 2411-8, Oct 2009.
13a Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM: Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31(8): 1000-6, Apr 2010.
172 Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, Gelfand JM: The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol 64(6): 1035-50, Jun 2011.
1bf Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM: Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 147(9): 1031-9, Sep 2011.
13f Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM: Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 132(3Pt1): 556-62, Mar 2012.
1d6 Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees AS: Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol 148(4): 487-94, Apr 2012.
12e Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM: Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol 148(9): 995-1000, Sep 2012.
149 Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A: Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). J Vis Exp 63: e3777, May 2012.
181 Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, Gelfand JM: Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol 68(1): 64-72, Jan 2013.
2c
51
22
22
7
10
a
a
2
2
19
18
10
22
10
11
c
5b © The Trustees of the University of Pennsylvania | Site best viewed a in a supported browser. | Site Design: 57 PMACS Web Team. 3 22
10